CatalystPit

PLRZPolyrizon Ltd.

NASDAQ · Surgical & Medical Instruments & Apparatus
Last close $10.78 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustrySurgical & Medical Instruments & Apparatus
RECENT INSIDER TRADES
  • 2026-04-01 · Carmel Liron (Director) · SELL
  • 2026-04-01 · Adler Oz (Director) · SELL
  • 2026-04-01 · Izraeli Tomer (Chief Executive Officer) · SELL
  • 2026-03-31 · Carmel Liron (Director) · SELL
  • 2026-03-31 · Izraeli Tomer (Chief Executive Officer) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders4
Shares held220,847
Value$2.50M
Percent of shares outstanding13.73%
As of quarter end2026-06-30
RECENT NEWS
  • Polyrizon files U.S. patent application for intranasal drug-delivery platform
  • Polyrizon reports GAAP EPS of -$0.79
  • Polyrizon enrolls first patient in U.S. clinical study of NASARIX
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Polyrizon Ltd. (PLRZ) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit